Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis
NCT: NCT07620678 · COMPLETED
Brief Summary
Lateral epicondylitis is a common musculoskeletal disorder associated with pain and impaired upper extremity function. The aim of this study was to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and single-session 5% dextrose prolotherapy (DPT) in patients with lateral epicondylitis and to evaluate the relative superiority of these treatment approaches during short- and mid-to-long-term follow-up. Ninety-six patients were allocated into three groups: conventional treatment alone, conventional treatment plus ESWT, and conventional treatment plus DPT. Pain, functional status, grip strength, and common extensor tendon thickness were evaluated during follow-up.
Frequently Asked Questions
What is Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis?
Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis is a clinical trial registered under NCT07620678. Current status: COMPLETED.
What is the status of NCT07620678?
The current status of NCT07620678 (Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis) is: COMPLETED.
When did Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis start?
Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis started on 2023-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.